Skip to main content

Meet the Team

Imbio draws on healthcare industry experience including sales, marketing, regulatory, and engineering to build the most powerful solutions for caregivers and millions of patients around the world. Our entire team combines a cutting-edge innovation mindset with a dedicated belief in making a real impact on the healthcare world today.

Executive Leadership

David Hannes

Chief Executive Officer

David Hannes is the Chief Executive Officer of Imbio, having joined in April, 2015. He brings nearly 20 years of experience across Commercial Operations, Business Development and Strategy in both Fortune 50 and start-up medical device business to the Imbio team.


    Prior to joining Imbio, Mr. Hannes was Vice President of Business Development for NeuWave Medical, a microwave ablation start-up based out of Madison, Wisconsin. Mr. Hannes joined NeuWave in its second year of commercial sales and was a key member of the leadership team which built the company into the market leader in microwave ablation, including gaining broad acceptance across the nation’s Top 50 cancer centers.

    Mr. Hannes led NeuWave’s Business Development and Strategy, corporate contracting and Marketing during this rapid transition from start-up to growth business. Prior to Neuwave, Mr. Hannes spent more than 14 years at GE Healthcare across a variety of operational and commercial leadership positions including Corporate Purchasing, Commercial Operations, Finance, and Global Service P&L leadership. Early in his career, Mr. Hannes was a manager in Ford Motor’s Corporate Purchasing group where he built his global commercial, strategy and lean manufacturing/operations experience. Mr. Hannes has a B.S. in Business from The University of Dayton and an MBA from the University of Madison – Wisconsin.

Neal Meyer

Chief Financial Officer

Neal Meyer has served as Chief Financial Officer of Imbio since June 2019. He is also the Chief Financial Officer of Invenshure where he oversees the company’s operations. Previously, he was a Senior Vice President at Winthrop Resources Corporation, a wholly-owned subsidiary of TCF Financial Corporation (NASDAQ: TCF), where he managed a $500 million technology finance portfolio. 


    Neal began his career in public accounting at Grant Thornton and holds a Bachelor of Arts degree from Gustavus Adolphus College. He is a Certified Public Accountant licensed in the state of Minnesota.

Danny Cunigan

Chairman of the Board

Danny Cunagin is the Chairman of the Board at Imbio and brings invaluable operational and strategic experience to the management team. Previously, he was the Chief Executive Officer and Chairman of the Board of Steady State Imaging, LLC where he led the commmercialization of a recently invented MRI technology and guided the sale of the company to GE Healthcare in 2011.


    From 2005 to 2008, Mr. Cunagin served as the President of Micro Dynamics and Logic Product Development, a product engineering and manufacturing company with over 400 employees and sales in excess of $90 million. Prior to the merger with Micro Dynamics, he was CEO, Chairman and majority owner of Logic Product Development.

    Under his guidance, Logic grew from startup into one of the largest fully integrated product development-consulting firms in the US with sales in excess of $45 million and more than 100 product development engineers located in several international locations. He is the author of two patents, was noted as one of “forty under 40” in 1999 by City Business and has a B.S.M.E. from the University of Kentucky. Away from work, Danny is an avid endurance athlete and a burgeoning yogi.

Clinical Advisory Board



D. Kyle Hogarth, MD, FCCP, is a Professor of Medicine in the Section of Pulmonary and
Critical Care Medicine at The University of Chicago. He is the Director of
Bronchoscopy and is heavily involved in the field of advanced bronchoscopy and
interventional pulmonary with numerous publications. He also runs the Alpha One
Antitrypsin Deficiency Clinical Resource Center, one of the largest in the Midwest with
over 250 patients.


    Dr. Hogarth received his medical degree at Case Western Reserve University School of Medicine in Cleveland, Ohio. He then completed a residency in Internal Medicine and a fellowship in Pulmonary and Critical Care at The University of Chicago. He has been published in the New England Journal of Medicine, Chest, ERJ and many other journals. He previously served on the editorial board of CHEST, where he was the section editor for the podcast section and giants in chest medicine series. He helped write the 2016 Alpha One Antitrypsin deficiency Clinical Practice Guidelines. He has won numerous clinical awards and teaching awards from his University. He is a founding member and the past President of the Society for Advanced Bronchoscopy.

Alnawaz Rehemtulla, PH.D.

Co-founder & Advisor

Dr. Rehemtulla is an endowed Professor of Radiation Oncology at the University of Michigan School of Medicine and serves as an advisor to Imbio. He is focused on the development of imaging biomarkers to improve the diagnosis and treatment of cancer patients.


    The majority of cancer patients are treated in part with ionizing radiation and Dr. Rehemtulla is well known among clinical Radiation Oncology departments. He has been instrumental in the development of the voxel-based technology and is a co-inventor on the licensed patents from the University of Michigan. Dr. Rehemtulla has a 20-year history of developing products in the fields of cancer and cardiovascular disease. He trained at the Scripps Research Institute in La Jolla, where he developed technologies for diagnostic use in cardiovascular diseases. While at the Genetics Institute in Cambridge MA, he was involved in the development of protein therapeutics for Hemophilia A and B, both of which are in use clinically.